Celldex Therapeutics CLDX Growth Metrics (2010-2026)

NASDAQ CLDX
$31.65 +0.16 (+0.51%)
As of: Sep 29, 2026 · 3:59 PM EDT
Reported Financials

Celldex Therapeutics Quarterly Growth Metrics

Periods 64 quarters
Latest Jun 2026

Celldex Therapeutics growth metrics data for the quarter ended Jun 2026. These growth metrics cover 64 quarters of results from Sep 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
EBITDA Margin Growth (1y)
-1.11M-0.52M-1.06M-2.15M0.65M0.42M0.96M0.98M0.40M0.06M-2.23M1.03M0.11M-0.36M1.66M-0.68M-6.67M-54.83M-35.37M
EBITDA Margin Growth (3y)
-1.24M-0.52M-1.17M-2.03M-0.47M-0.04M-0.29M-0.78M-0.06M-0.05M-2.32M-0.15M1.15M0.12M0.40M1.32M-6.97M-55.39M-35.03M
EBITDA Margin Growth (5y)
-1.18M-0.41M-1.07M-2.12M-0.59M-0.10M-0.04M-1.15M-0.19M-0.05M-2.44M-0.03M0.03M-0.34M-0.85M-0.43M-7.07M-55.49M-36.20M
EBITDA Margin (QoQ)
-1.28M0.73M-0.70M-0.90M1.52M0.50M-0.16M-0.88M0.94M0.15M-2.44M2.37M0.02M-0.31M-0.42M0.03M-48.59M19.48M
EBIT Margin Growth (1y)
-1.15M-0.54M-1.09M-2.19M0.68M0.44M1.00M0.99M0.41M0.06M-2.27M1.05M0.11M-0.36M1.70M-0.69M-6.73M-55.39M-35.77M
EBIT Margin Growth (3y)
-1.28M-0.54M-1.21M-2.06M-0.46M-0.03M-0.29M-0.76M-0.06M-0.05M-2.36M-0.15M1.20M0.13M0.43M1.36M-7.03M-55.95M-35.41M
EBIT Margin Growth (5y)
-1.23M-0.42M-1.11M-2.16M-0.60M-0.10M-0.04M-1.18M-0.19M-0.05M-2.48M-0.01M0.05M-0.33M-0.86M-0.39M-7.14M-56.05M-36.61M
EBIT Margin (QoQ)
-1.32M0.75M-0.73M-0.90M1.55M0.51M-0.16M-0.90M0.97M0.16M-2.49M2.42M0.02M-0.31M-0.43M0.03M-49.09M19.64M
EBT Margin Growth (1y)
-1.14M-0.54M-1.08M-2.17M0.69M0.44M1.02M1.07M0.41M0.06M-1.80M0.99M0.12M-0.30M1.33M-0.63M-6.32M-51.68M-32.64M
EBT Margin Growth (3y)
-1.27M-0.55M-1.20M-2.04M-0.45M-0.05M-0.26M-0.66M-0.04M-0.04M-1.86M-0.11M1.22M0.20M0.55M1.43M-6.56M-52.15M-32.27M
EBT Margin Growth (5y)
-1.22M-0.43M-1.10M-2.13M-0.58M-0.10M-0.01M-1.08M-0.18M-0.05M-1.98M0.02M0.08M-0.28M-0.73M-0.30M-6.66M-52.22M-33.37M
EBT Margin (QoQ)
-1.31M0.75M-0.72M-0.88M1.55M0.49M-0.14M-0.83M0.89M0.15M-2.00M1.96M0.01M-0.27M-0.37M-0.00M-45.74M19.05M
FCF Margin Growth (1y)
-0.90M-0.43M-1.17M-1.37M0.21M0.31M1.14M0.38M0.75M0.06M-2.33M0.91M-0.05M-0.20M1.84M-0.49M-5.11M-44.04M-26.92M
FCF Margin Growth (3y)
-0.93M-0.36M-1.35M-1.25M-0.67M-0.01M-0.26M-0.52M0.05M-0.07M-2.35M-0.08M0.91M0.16M0.66M0.79M-5.25M-44.52M-26.51M
FCF Margin Growth (5y)
-0.97M-0.33M-1.21M-1.35M-0.81M-0.08M-0.23M-0.97M0.03M0.01M-2.53M0.04M0.03M-0.16M-0.74M-0.10M-5.38M-44.55M-27.50M
FCF Margin (QoQ)
-1.05M0.64M-1.00M0.04M0.53M0.74M-0.17M-0.73M0.90M0.05M-2.55M2.51M-0.06M-0.11M-0.50M0.17M-39.44M17.29M
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
Net Margin Growth (1y)
-1.12M-0.55M-1.08M-2.17M0.68M0.44M1.02M1.07M0.41M0.06M-1.80M0.99M0.12M-0.30M1.33M-0.63M-6.32M-51.68M-32.64M
Net Margin Growth (3y)
-1.26M-0.55M-1.20M-2.04M-0.45M-0.05M-0.26M-0.67M-0.04M-0.05M-1.86M-0.11M1.20M0.20M0.55M1.43M-6.56M-52.15M-32.27M
Net Margin Growth (5y)
-1.20M-0.43M-1.10M-2.13M-0.59M-0.15M-0.01M-1.08M-0.18M-0.05M-1.98M0.02M0.08M-0.28M-0.73M-0.31M-6.67M-52.22M-33.37M
Net Margin (QoQ)
-1.30M0.73M-0.72M-0.88M1.55M0.49M-0.14M-0.83M0.89M0.15M-2.00M1.96M0.01M-0.27M-0.37M-0.00M-45.73M19.05M
Operating Margin Growth (1y)
-1.15M-0.54M-1.09M-2.19M0.68M0.44M1.00M0.99M0.41M0.06M-2.27M1.05M0.11M-0.36M1.70M-0.69M-6.73M-55.39M-35.77M
Operating Margin Growth (3y)
-1.28M-0.54M-1.21M-2.06M-0.46M-0.03M-0.29M-0.76M-0.06M-0.05M-2.36M-0.15M1.20M0.13M0.43M1.36M-7.03M-55.95M-35.41M
Operating Margin Growth (5y)
-1.23M-0.42M-1.11M-2.16M-0.60M-0.10M-0.04M-1.18M-0.19M-0.05M-2.48M-0.01M0.05M-0.33M-0.86M-0.39M-7.14M-56.05M-36.61M
Operating Margin (QoQ)
-1.32M0.75M-0.73M-0.90M1.55M0.51M-0.16M-0.90M0.97M0.16M-2.49M2.42M0.02M-0.31M-0.43M0.03M-49.09M19.64M
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-361.00948.000.00M794.00-516.00-0.00M-0.00M-0.00M-0.00M-681.000.00M0.00M0.00M0.00M-164.00-0.00M-0.00M-0.00M-0.00M-0.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
0.01M0.01M0.00M741.00891.00882.00427.00-0.00M-0.00M-0.00M710.000.00M383.00-396.00-562.00-378.00-604.00-0.00M-0.00M-0.00M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
0.00M0.00M0.00M0.00M906.00-182.000.00M0.01M0.00M0.01M0.00M0.00M0.00M0.00M0.00M-353.00-0.00M-0.00M-0.00M-0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ)
975.00671.00-215.00-637.00-335.00-367.00-392.00-124.00-673.00508.000.00M419.00-94.00-108.00-381.00-453.00-561.00-853.00-982.00538.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-286.000.00M0.00M879.00-534.00-0.00M-0.00M-0.00M-0.00M-0.00M0.00M0.00M0.00M0.00M-422.00-0.00M-0.00M-0.00M-0.00M-0.00M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
0.01M0.01M0.00M0.00M0.00M0.00M830.00-0.00M-0.00M-0.00M651.000.00M52.00-905.00-0.00M-809.00-0.00M-0.00M-0.00M-0.00M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
0.00M0.00M0.00M0.00M0.00M828.000.01M0.01M0.01M0.01M0.00M0.00M0.00M0.00M0.00M-651.00-0.00M-0.00M-0.00M-0.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
0.00M744.00-220.00-774.00-284.00-454.00-482.00-245.00-0.00M625.000.00M419.00-208.00-212.00-420.00-477.00-670.00-982.00-0.00M670.00
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
-331.000.00M0.00M995.00-589.00-0.00M-0.00M-0.00M-0.00M-840.000.00M0.00M0.00M0.00M-181.00-0.00M-0.00M-0.00M-0.00M-0.00M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
0.01M0.01M0.00M0.00M0.00M0.00M0.00M-0.00M-0.00M-0.00M962.000.00M468.00-413.00-583.00-327.00-598.00-0.00M-0.00M-0.00M
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
0.00M0.00M0.00M0.00M0.00M740.000.01M0.01M0.01M0.01M0.00M0.00M0.00M0.00M0.00M-113.00-0.00M-0.00M-0.00M-0.00M
Return on Equity [ROE] (QoQ)ROE (QoQ)
0.00M747.00-237.00-727.00-372.00-362.00-428.00-127.00-854.00569.000.00M467.00-108.00-133.00-407.00-472.00-643.00-0.00M-0.00M635.00
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
-1.15M-0.54M-1.09M-2.19M0.68M0.44M1.00M0.99M0.41M0.06M-2.27M1.05M0.11M-0.36M1.70M-0.69M-0.82M-6.73M-55.39M-35.77M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
-1.28M-0.54M-1.21M-2.06M-0.46M-0.03M-0.29M-0.76M-0.06M-0.05M-2.36M-0.15M1.20M0.13M0.43M1.36M-0.31M-7.03M-55.95M-35.41M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
-1.23M-0.42M-1.11M-2.16M-0.60M-0.10M-0.04M-1.18M-0.19M-0.05M-2.48M-0.01M0.05M-0.33M-0.86M-0.39M-0.77M-7.14M-56.05M-36.61M
Return on Sales [ROS] (QoQ)ROS (QoQ)
-1.32M0.75M-0.73M-0.90M1.55M0.51M-0.16M-0.90M0.97M0.16M-2.49M2.42M0.02M-0.31M-0.43M0.03M-0.11M-6.22M-49.09M19.64M

Celldex Therapeutics Growth Metrics API

Pull Celldex Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CLDX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY